These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296 [TBL] [Abstract][Full Text] [Related]
6. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences. Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147 [TBL] [Abstract][Full Text] [Related]
7. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856 [TBL] [Abstract][Full Text] [Related]
8. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624 [TBL] [Abstract][Full Text] [Related]
9. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
11. Prognostic models and algorithms in renal cell carcinoma. Lane BR; Kattan MW Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615 [TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550 [TBL] [Abstract][Full Text] [Related]
13. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. Lee SE; Byun SS; Han JH; Han BK; Hong SK BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508 [TBL] [Abstract][Full Text] [Related]
16. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278 [TBL] [Abstract][Full Text] [Related]
17. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125 [TBL] [Abstract][Full Text] [Related]
18. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [TBL] [Abstract][Full Text] [Related]
19. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704 [TBL] [Abstract][Full Text] [Related]